Completed NA INTERVENTIONAL 2-arm NCT03970291

Impact of NOL Intraoperative Guided Fentanyl Analgesia vs SCC for Elective Major Abdominal Surgery

Impact of Nociceptive-Level (NOL) Intraoperative Guided Fentanyl Analgesia Versus Standard Clinical Care (SCC) for Elective Major Abdominal Surgery

Sponsor: Medasense Biometrics Ltd

Conditions Anesthesia

Interventions PMD-200

Updated 10 times since 2019 Last updated: Jan 16, 2022 Started: Nov 1, 2019 Primary completion: May 30, 2021 Completion: Jun 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anesthesia, this trial is completed. The trial is conducted by Medasense Biometrics Ltd and has accumulated 10 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2022 — Jul 2024 [monthly]

Completed NA
Sep 2021 — Feb 2022 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2021 — Sep 2021 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 5 earlier versions

Jan 2021 — Jun 2021 [monthly]

Recruiting NA
Apr 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2019 — Apr 2020 [monthly]

Not Yet Recruiting NA
Jul 2019 — Sep 2019 [monthly]

Not Yet Recruiting NA
Jun 2019 — Jul 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medasense Biometrics Ltd

Data source: Medasense Biometrics Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel